Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 40 Researches
7.3
USERS' SCORE
Good
Based on 9 Reviews
8.7
Supplement Facts
Serving Size: 3 Caplets
Amount Per Serving
%DV
Vitamin D (as D3 Cholecalciferol)
15 mcg (600 IU)
75%
Calcium (as Calcium Carbonate and Calcium Gluconate)
1,000 mg
77%
Magnesium (as Magnesium Oxide and Magnesium Gluconate)
400 mg
95%
Zinc (as Zinc Gluconate and Zinc Citrate)
25 mg
227%
Sodium
10 mg
<1%
Top Medical Research Studies
9
Vitamin D supports depression management
We conducted a double-blind, randomized, placebo-controlled trial to explore how cholecalciferol, a form of vitamin D, influences depressive symptoms in individuals suffering from type 2 diabetes mellitus (T2DM). This clinical study lasted for 12 weeks and involved participants who were either given a daily dose of 4000 IU of cholecalciferol or a placebo.
Throughout the study, we measured various factors, including the participants’ depression levels using the Beck Depression Inventory-II, as well as important biological markers like C-peptide, serotonin, and neurotrophin-3.
Our findings showed a significant reduction in depression scores among those taking cholecalciferol compared to the placebo group. Additionally, we observed a notable increase in C-peptide levels, which may indicate some metabolic benefits, although no significant changes were found in serotonin and neurotrophin-3 levels.
Ultimately, while cholecalciferol appears to alleviate mild to moderate depressive symptoms in T2DM patients through improved C-peptide levels, its impact on serotonin and neurotrophin-3 remains unclear. This highlights vitamin D as a potentially helpful option for managing depression alongside diabetes.
Throughout the study, we measured various factors, including the participants’ depression levels using the Beck Depression Inventory-II, as well as important biological markers like C-peptide, serotonin, and neurotrophin-3.
Our findings showed a significant reduction in depression scores among those taking cholecalciferol compared to the placebo group. Additionally, we observed a notable increase in C-peptide levels, which may indicate some metabolic benefits, although no significant changes were found in serotonin and neurotrophin-3 levels.
Ultimately, while cholecalciferol appears to alleviate mild to moderate depressive symptoms in T2DM patients through improved C-peptide levels, its impact on serotonin and neurotrophin-3 remains unclear. This highlights vitamin D as a potentially helpful option for managing depression alongside diabetes.
Read More
9
We conducted a systematic review and meta-analysis exploring how dietary magnesium (Mg) intake connects with depression among adults. By reviewing data from over 63,000 individuals, we found that those with the highest magnesium intake had a 34% lower chance of experiencing depression compared to those with the lowest intake.
Furthermore, our analysis indicated that every increase of 100 mg per day in magnesium intake was linked to a 7% reduced risk of depression. These findings suggest that increasing dietary magnesium could play a valuable role in lowering depression risk.
Furthermore, our analysis indicated that every increase of 100 mg per day in magnesium intake was linked to a 7% reduced risk of depression. These findings suggest that increasing dietary magnesium could play a valuable role in lowering depression risk.
Read More
8
We examined the connection between vitamin D deficiency (VDD) and depression in patients with chronic kidney disease (CKD). Our research, which utilized a large database from the TriNetX network, involved over 17,900 matched CKD patients aged 50 and older. They were divided into two groups based on their vitamin D levels: those with deficiency (20 ng/mL or lower) and those with adequate levels (30 ng/mL or higher).
The findings were striking. We discovered that those with VDD had nearly double the risk of developing depression within a year compared to those with sufficient vitamin D levels. This risk was especially pronounced in men and remained consistent across different stages of CKD. Even patients who had borderline low vitamin D levels faced an increased chance of depression.
Our study suggests that maintaining adequate vitamin D levels might be crucial for mental health in CKD patients. However, we also recognize the need for further randomized trials to definitively establish whether vitamin D supplementation can help prevent depression in these individuals. The implications of our findings could pave the way for new approaches to managing mental health in patients dealing with CKD.
The findings were striking. We discovered that those with VDD had nearly double the risk of developing depression within a year compared to those with sufficient vitamin D levels. This risk was especially pronounced in men and remained consistent across different stages of CKD. Even patients who had borderline low vitamin D levels faced an increased chance of depression.
Our study suggests that maintaining adequate vitamin D levels might be crucial for mental health in CKD patients. However, we also recognize the need for further randomized trials to definitively establish whether vitamin D supplementation can help prevent depression in these individuals. The implications of our findings could pave the way for new approaches to managing mental health in patients dealing with CKD.
Read More
Most Useful Reviews
9.5
Greater well-being achieved
Wonderful! This is like a dream. All signs of depression and fatigue are gone. I take it at night every day, and I feel fantastic.
Read More
9.5
Calmness restored
This complex of Calcium, Magnesium, Zinc, and Vitamin D3 has been a constant in my routine. Initially purchased to address magnesium deficiency, it has greatly helped with my post-covid depression. I feel much calmer and less tense. I highly recommend it.
Read More
9.5
Mood improvement
I have purchased these vitamins multiple times. Following the birth of my daughter, I fell into depression, which resulted in restless nights and persistent fatigue. However, once I started taking these vitamins, my fatigue and nervousness diminished, my mood significantly improved, and I noticed that my hair was no longer falling out. I am genuinely pleased with the outcome.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 40 Researches
7.3
- All Researches
9.5
Magnesium and Vitamin D effective for depression
We explored the effectiveness of magnesium coupled with vitamin D in easing depressive symptoms among individuals with long-COVID. Our study involved 60 participants suffering from mild to moderate depression, hypomagnesemia, and vitamin D deficiency.
Over four months, those who received both magnesium and vitamin D showed significant improvements in their depression scores compared to those who only took vitamin D. Specifically, a notable 73% of the magnesium group achieved significant relief, positioning this combination as a promising treatment for depression linked to long-COVID.
Mild side effects were noted but did not lead to any withdrawals, indicating the safety of this treatment option.
Over four months, those who received both magnesium and vitamin D showed significant improvements in their depression scores compared to those who only took vitamin D. Specifically, a notable 73% of the magnesium group achieved significant relief, positioning this combination as a promising treatment for depression linked to long-COVID.
Mild side effects were noted but did not lead to any withdrawals, indicating the safety of this treatment option.
Read More
9
Vitamin D and Magnesium Aid Depression
We conducted a study to evaluate whether supplementing with magnesium and vitamin D could help alleviate mild-to-moderate depressive symptoms in individuals suffering from long-COVID. The clinical trial included 60 participants, aged 52.8 years on average, who had been diagnosed with hypomagnesemia, vitamin D deficiency, and mild-to-moderate depression.
Participants were divided into two groups: one received magnesium chloride along with vitamin D, while the other group only received vitamin D. Over four months, we monitored the effectiveness of these supplements in reducing depressive symptoms, using the Beck Depression Inventory (BDI) scale to measure changes.
Our results revealed a significant reduction in depressive symptoms for those taking both magnesium and vitamin D, with 73.2% of them reaching a positive outcome score on the BDI. In contrast, the control group, which received only vitamin D, showed a less dramatic improvement, suggesting that the combined treatment may offer more benefits for those struggling with depression related to long-COVID.
While both groups experienced some improvement, our findings indicate that magnesium plus vitamin D supplementation presents a promising option for individuals coping with depression in the wake of COVID-19.
Participants were divided into two groups: one received magnesium chloride along with vitamin D, while the other group only received vitamin D. Over four months, we monitored the effectiveness of these supplements in reducing depressive symptoms, using the Beck Depression Inventory (BDI) scale to measure changes.
Our results revealed a significant reduction in depressive symptoms for those taking both magnesium and vitamin D, with 73.2% of them reaching a positive outcome score on the BDI. In contrast, the control group, which received only vitamin D, showed a less dramatic improvement, suggesting that the combined treatment may offer more benefits for those struggling with depression related to long-COVID.
While both groups experienced some improvement, our findings indicate that magnesium plus vitamin D supplementation presents a promising option for individuals coping with depression in the wake of COVID-19.
Read More
9
Vitamin D supports depression management
We conducted a double-blind, randomized, placebo-controlled trial to explore how cholecalciferol, a form of vitamin D, influences depressive symptoms in individuals suffering from type 2 diabetes mellitus (T2DM). This clinical study lasted for 12 weeks and involved participants who were either given a daily dose of 4000 IU of cholecalciferol or a placebo.
Throughout the study, we measured various factors, including the participants’ depression levels using the Beck Depression Inventory-II, as well as important biological markers like C-peptide, serotonin, and neurotrophin-3.
Our findings showed a significant reduction in depression scores among those taking cholecalciferol compared to the placebo group. Additionally, we observed a notable increase in C-peptide levels, which may indicate some metabolic benefits, although no significant changes were found in serotonin and neurotrophin-3 levels.
Ultimately, while cholecalciferol appears to alleviate mild to moderate depressive symptoms in T2DM patients through improved C-peptide levels, its impact on serotonin and neurotrophin-3 remains unclear. This highlights vitamin D as a potentially helpful option for managing depression alongside diabetes.
Throughout the study, we measured various factors, including the participants’ depression levels using the Beck Depression Inventory-II, as well as important biological markers like C-peptide, serotonin, and neurotrophin-3.
Our findings showed a significant reduction in depression scores among those taking cholecalciferol compared to the placebo group. Additionally, we observed a notable increase in C-peptide levels, which may indicate some metabolic benefits, although no significant changes were found in serotonin and neurotrophin-3 levels.
Ultimately, while cholecalciferol appears to alleviate mild to moderate depressive symptoms in T2DM patients through improved C-peptide levels, its impact on serotonin and neurotrophin-3 remains unclear. This highlights vitamin D as a potentially helpful option for managing depression alongside diabetes.
Read More
9
We conducted a systematic review and meta-analysis exploring how dietary magnesium (Mg) intake connects with depression among adults. By reviewing data from over 63,000 individuals, we found that those with the highest magnesium intake had a 34% lower chance of experiencing depression compared to those with the lowest intake.
Furthermore, our analysis indicated that every increase of 100 mg per day in magnesium intake was linked to a 7% reduced risk of depression. These findings suggest that increasing dietary magnesium could play a valuable role in lowering depression risk.
Furthermore, our analysis indicated that every increase of 100 mg per day in magnesium intake was linked to a 7% reduced risk of depression. These findings suggest that increasing dietary magnesium could play a valuable role in lowering depression risk.
Read More
9
We investigated the potential benefits of a novel zinc complex, specifically Zn(ALC)Cl(HO), for its effectiveness in treating depression. This innovative compound combines zinc with acetyl-l-carnitine, which is known for its role in energy metabolism and protecting brain cells.
Our findings revealed that this zinc complex displays a remarkable 54% improvement in antidepressant activity compared to standard acetyl-l-carnitine. We also observed its ability to reduce pain in tests involving chronic conditions, showing promise in enhancing overall mental and physical health.
Additionally, this compound demonstrated capability to cross the blood-brain barrier, protecting against cell damage from excessive glutamate. We think these results indicate that Zn(ALC)Cl(HO) could be a significant step forward in managing not just depression but also neurodegenerative challenges.
Our findings revealed that this zinc complex displays a remarkable 54% improvement in antidepressant activity compared to standard acetyl-l-carnitine. We also observed its ability to reduce pain in tests involving chronic conditions, showing promise in enhancing overall mental and physical health.
Additionally, this compound demonstrated capability to cross the blood-brain barrier, protecting against cell damage from excessive glutamate. We think these results indicate that Zn(ALC)Cl(HO) could be a significant step forward in managing not just depression but also neurodegenerative challenges.
Read More
User Reviews
USERS' SCORE
Good
Based on 9 Reviews
8.7
- All Reviews
- Positive Reviews
- Negative Reviews
9.5
Greater well-being achieved
Wonderful! This is like a dream. All signs of depression and fatigue are gone. I take it at night every day, and I feel fantastic.
Read More
9.5
Calmness restored
This complex of Calcium, Magnesium, Zinc, and Vitamin D3 has been a constant in my routine. Initially purchased to address magnesium deficiency, it has greatly helped with my post-covid depression. I feel much calmer and less tense. I highly recommend it.
Read More
9.5
Mood improvement
I have purchased these vitamins multiple times. Following the birth of my daughter, I fell into depression, which resulted in restless nights and persistent fatigue. However, once I started taking these vitamins, my fatigue and nervousness diminished, my mood significantly improved, and I noticed that my hair was no longer falling out. I am genuinely pleased with the outcome.
Read More
8.8
Feeling better overall
I drank this complex for over a week. There was a difficult period in my life with a lot of stress, and depression had affected me greatly. So far, I feel much better, and I hope my condition continues to improve. I take two tablets in the morning and evening, and there are no side effects.
Read More
8.8
Improved health benefits
I read reviews about this complex and realised how necessary it is for our health. I take one a day. Magnesium has relieved my cramps, calcium may strengthen bones, and zinc aids healing. It has accelerated my healing process. By normalising magnesium levels in the body, issues like insomnia, stress, and depression can be alleviated. Zinc plays a vital role in bone formation and supports the immune system. Be healthy!
Read More
Frequently Asked Questions
No FAQs are available for this product and symptom.
References
- Ielmini M, Gallo D, Tanda ML, Piantanida E, Callegari C, et al. Assessment of the Correlation Between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Cross-Sectional Study. Psychopharmacol Bull. 2025;55:8.
- Askarpour M, Hejazi N, Jahromi BN, Eskandari MH, Famouri M, et al. Effects of a Novel Fortified Dairy Product on the Psychological Status and Sleep Quality of Patients with Polycystic Ovary Syndrome: A Double-Blind Randomized Controlled Trial. Prev Nutr Food Sci. 2025;30:37. doi:10.3746/pnf.2025.30.1.37
- Xu X, Jing F, Zhong H, Lin L, Gao T, et al. Synergistic impact of 25-hydroxyvitamin D and physical activity on incident depression: Evidence from prospective cohorts and genome-wide data. J Affect Disord. 2025. doi:10.1016/j.jad.2025.03.004
- Bostan ZZ, Şare Bulut M, Gezmen Karadağ M. Can Vıtamın D Reduce the Need for SSRI by Modulatıng Serotonın Synthesıs?: A Revıew of Recent Lıterature. Curr Nutr Rep. 2025;14:39. doi:10.1007/s13668-025-00630-7
- Yu C, Liu K, Yao W, Tang D. Associations between the intake of single and multiple dietary vitamins and depression risk among populations with chronic kidney disease. Front Nutr. 2025;12:1492829. doi:10.3389/fnut.2025.1492829
- Chen IW, Wang WT, Lai YC, Chang YJ, Lin YT, et al. Association between vitamin D deficiency and major depression in patients with chronic kidney disease: a cohort study. Front Nutr. 2025;12:1540633. doi:10.3389/fnut.2025.1540633
- Raza ML, Hassan ST, Jamil S, Fatima W, Fatima M. Nutritional interventions in depression: The role of vitamin D and omega-3 fatty acids in neuropsychiatric health. Clin Nutr. 2025;45:270. doi:10.1016/j.clnu.2025.01.009
- Rodríguez-Morán M, Guerrero-Romero F, Barragán-Zuñiga J, Gamboa-Gómez CI, Weyman-Vela Y, et al. Combined oral supplementation with magnesium plus vitamin D alleviates mild to moderate depressive symptoms related to long-COVID: an open-label randomized, controlled clinical trial. Magnes Res. 2024;37:49. doi:10.1684/mrh.2024.0535
- Yuan Y, Qu L, Sun Q, He P, Zhou X. The Association between Vitamin D Deficiency and Perinatal Depression: A Systematic Review and Meta-Analysis. Alpha Psychiatry. 2024;25:669. doi:10.5152/alphapsychiatry.2024.241553
- Jiang R, Lu M, Hua Y, Hong Z. Association between serum vitamin D and depression among non-alcoholic fatty liver disease. Asia Pac J Clin Nutr. 2025;34:112. doi:10.6133/apjcn.202502_34(1).0011
- Putranto R, Setiati S, Nasrun MW, Witjaksono F, Immanuel S, et al. Effects of cholecalciferol supplementation on depressive symptoms, C-peptide, serotonin, and neurotrophin-3 in type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial. Narra J. 2024;4:e1342. doi:10.52225/narra.v4i3.1342
- Ghaemi S, Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S. The effect of vitamin D supplementation on depression: a systematic review and dose-response meta-analysis of randomized controlled trials. Psychol Med. 2024;54:1. doi:10.1017/S0033291724001697
- Carnegie RE, Zheng J, Borges MC, Jones HJ, Wade KH, et al. Micronutrients and Major Depression: A Mendelian Randomisation Study. Nutrients. 2024;16. doi:10.3390/nu16213690
- Centeno LOL, Fernandez MDS, Muniz FWMG, Longoni A, de Assis AM. Is Serum Vitamin D Associated with Depression or Anxiety in Ante- and Postnatal Adult Women? A Systematic Review with Meta-Analysis. Nutrients. 2024;16. doi:10.3390/nu16213648
- Karnopp TE, Chapacais GF, Gasparini ML, Dos Santos NG, Freitas VDS, et al. The role of vitamin D: a promising pathway to combat neuropsychiatric lupus disorders. Clin Exp Immunol. 2025;219. doi:10.1093/cei/uxae099
- Santos HGD, Longoni A, Trettim JP, Lemes IT, Menchaca JC, et al. Deficiency of vitamin D is associated with antenatal depression: A cross-sectional study. Trends Psychiatry Psychother. 2024. doi:10.47626/2237-6089-2024-0908
- Wu J, Jiang Y, Liang J, Zhou Y, Chai S, et al. Bidirectional causality between micronutrients and mental illness: Mendelian randomization studies. J Affect Disord. 2025;369:718. doi:10.1016/j.jad.2024.09.047
- Serefko A, Lachowicz-Radulska J, Szopa A, Herbet M, Czylkowska A, et al. The Novel Imipramine-Magnesium Complex Exerts Antidepressant-like Activity in Mice Subjected to the Forced Swim Test and the Tail Suspension Test. Molecules. 2025;30. doi:10.3390/molecules30030519
- Bardinet J, Pouchieu C, Chuy V, Merle B, Pellay H, et al. Association between nutrient patterns and odds of depressive symptomatology: a population-based cohort of older adults followed during 15-y. Eur J Nutr. 2025;64:88. doi:10.1007/s00394-025-03597-x
- Rodríguez-Morán M, Guerrero-Romero F, Barragán-Zuñiga J, Gamboa-Gómez CI, Weyman-Vela Y, et al. Combined oral supplementation with magnesium plus vitamin D alleviates mild to moderate depressive symptoms related to long-COVID: an open-label randomized, controlled clinical trial. Magnes Res. 2024;37:49. doi:10.1684/mrh.2024.0535
- Zhao W, Jin H. Magnesium depletion score and depression: a positive correlation among US adults. Front Public Health. 2024;12:1486434. doi:10.3389/fpubh.2024.1486434
- Carnegie RE, Zheng J, Borges MC, Jones HJ, Wade KH, et al. Micronutrients and Major Depression: A Mendelian Randomisation Study. Nutrients. 2024;16. doi:10.3390/nu16213690
- Cai Z, She J, Liu X, Li R, Guo S, et al. Associations between magnesium depletion score and depression among individuals aged 20 to 60 years. J Trace Elem Med Biol. 2024;86:127543. doi:10.1016/j.jtemb.2024.127543
- Strodl E, Bambling M, Parnam S, Ritchie G, Cramb S, et al. Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial. Sci Rep. 2024;14:20841. doi:10.1038/s41598-024-71093-z
- Hajhashemy Z, Shirani F, Askari G. Dietary Magnesium Intake in Relation to Depression in Adults: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis of Epidemiologic Studies. Nutr Rev. 2025;83:217. doi:10.1093/nutrit/nuae056
- Abdelmoneam AH, Khafagy GM, Elbeh KA, Hasan MDA. Impact of Magnesium and Ferritin Deficiency on Depression Among Adolescent Students. J Prim Care Community Health. 2024;15:21501319241252570. doi:10.1177/21501319241252570
- Chou MH, Yang YK, Wang JD, Lin CY, Lin SH. Elevated C-Reactive Protein Levels Modify the Effect of Magnesium on Depressive Symptoms: A Population-Based Study. Nutrients. 2023;15. doi:10.3390/nu15071560
- Chou MH, Yang YK, Wang JD, Lin CY, Lin SH. The Association of Serum and Dietary Magnesium with Depressive Symptoms. Nutrients. 2023;15. doi:10.3390/nu15030774
- Li Z, Chen K, Shao Q, Lu H, Zhang X, et al. Nanoparticulate MgH ameliorates anxiety/depression-like behaviors in a mouse model of multiple sclerosis by regulating microglial polarization and oxidative stress. J Neuroinflammation. 2023;20:16. doi:10.1186/s12974-023-02696-y
- Wang H, Jin M, Xie M, Yang Y, Xue F, et al. Protective role of antioxidant supplementation for depression and anxiety: A meta-analysis of randomized clinical trials. J Affect Disord. 2023;323:264. doi:10.1016/j.jad.2022.11.072
- Saba S, Faizi F, Sepandi M, Nehrir B. Effect of short-term magnesium supplementation on anxiety, depression and sleep quality in patients after open-heart surgery. Magnes Res. 2022;35:62. doi:10.1684/mrh.2022.0503
- Abiri B, Sarbakhsh P, Vafa M. Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms. Nutr Neurosci. 2022;25:2123. doi:10.1080/1028415X.2021.1945859
- Miller ES, Sakowicz A, Roy A, Wang A, Yang A, et al. Is peripartum magnesium sulfate associated with a reduction in postpartum depressive symptoms?. Am J Obstet Gynecol MFM. 2021;3:100407. doi:10.1016/j.ajogmf.2021.100407
- Caro-Ramírez JY, Bazán LO, Piro OE, Echeverría GA, Jori K, et al. Exploring Zn(II)-Acetyl l-carnitine complex for simultaneous management of depression, chronic pain, and neuroprotection. J Inorg Biochem. 2025;267:112857. doi:10.1016/j.jinorgbio.2025.112857
- Siodłak D, Doboszewska U, Nowak G, Wlaź P, Mlyniec K. Investigating the role of GPR39 in treatment of stress-induced depression and anxiety. Psychopharmacology (Berl). 2025. doi:10.1007/s00213-024-06736-0
- Sakae K, Suka M, Yanagisawa H. Dissociative Identity Disorder Cotreated With Zinc and L-carnosine: A Case Report. Cureus. 2024;16:e74794. doi:10.7759/cureus.74794
- Gąsior Ł, Pochwat B, Zaręba-Kozioł M, Włodarczyk J, Grabrucker AM, et al. Proteomics analysis in rats reveals convergent mechanisms between major depressive disorder and dietary zinc deficiency. Pharmacol Rep. 2025;77:145. doi:10.1007/s43440-024-00681-7
- Chrobak AA, Siwek M. Drugs with glutamate-based mechanisms of action in psychiatry. Pharmacol Rep. 2024;76:1256. doi:10.1007/s43440-024-00656-8
- Gong M, Fang Y, Yang K, Yuan F, Hu R, et al. The WFS1-ZnT3-Zn Axis Regulates the Vicious Cycle of Obesity and Depression. Adv Sci (Weinh). 2024;11:e2403405. doi:10.1002/advs.202403405
- Apryatin S, Lopachev A, Zhukov I, Efimova E, Apryatina V. BEHAVIORAL AND NEUROCHEMICAL CHANGES DURING INTRANASAL ADMINISTRATION OF ALPHA-GLUTAMYL-TRYPTOPHAN AND CHELATE COMPLEX OF ZINC ARGINYL-GLYCINATE ON MONOAMINE SYSTEMS DYSFUNCTIONS KNOCK-OUT MODELS. Georgian Med News. 2024.
